참고문헌
- Nathan MD, Davidson MB, DeFronzo RA, Heine RJ, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30:753-759 https://doi.org/10.2337/dc07-9920
- Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Y azdi H. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. AHRQ Study 2006;128:1-12
- Levitan EB, Song Y, Ford ES, Liu S Is non-diabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164:2147-2155 https://doi.org/10.1001/archinte.164.19.2147
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care July 2009 vol. 32 no. 7 1327-1334 https://doi.org/10.2337/dc09-9033
- Eldin WS, Emara M, Shoker A. Prediabetes: a must to recognise disease state. Int J Clin Pract 2008;62:642-648 https://doi.org/10.1111/j.1742-1241.2008.01705.x
- Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006;38: 52-63 https://doi.org/10.1080/07853890500383895
- Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;3:35-42 https://doi.org/10.1038/ncpcardio0380
- SjostromL, Kvist H, Cederblad A, Tyle'n U. Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium. Am J Physiol 1986:250: E736-745
- Jae Ryoung Seo, San Soo Bae. The Effect of Metabolic Syndrome Management Program in a Public Health Center. J Agric Med Community Health 2011:36(4):264-279 (Korean) https://doi.org/10.5393/JAMCH.2011.36.4.264
- Lemieux S, Tremblay A, Prud-Homme D, Bouchard C, Nadeau A, Despres JP. Sevenyear changes in body fat and visceral adipose tissue in women: associations with indexes of plasma glucose-insulin homeostasis. Diabetes Care 1996;19:983-991 https://doi.org/10.2337/diacare.19.9.983
- Mori Y, Hoshino K, Yokota K, Itoh Y, Tajima N. Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation: a study in pre-diabetic Japanese middle-aged men. Endocrine 2006;29:149-153 https://doi.org/10.1385/ENDO:29:1:149
- Jazet IM, Pijl H, Meinders AE. Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 2003; 61:194-212
- Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased Insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican- American. Diabetes 1995;44:1386-1391 https://doi.org/10.2337/diabetes.44.12.1386
- Avogaro A. Insulin resistance: trigger or concomitant factor in the metabolic syndrome. Panminerva Med 2006;48:3-12
- Abdul-Ghani MA, DeFronzo RA. Pathophysiology of prediabetes. Curr Diab Rep 2009;9:193-199 https://doi.org/10.1007/s11892-009-0032-7
- Basat O, Ucak S, Ozkurt H, Basak M, Seber S, Altuntas Y. Visceral adipose tissue as an indicator of insulin resistance in nonobese patients with new onset type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2006 Feb;114(2):58-62 https://doi.org/10.1055/s-2006-923886
- Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, Kawata M, Yamanouchi K, Okumura T, Doi K, Tokuyama K, Nagasaka S, Fukushima M. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 2002 May;51(5):544-548 https://doi.org/10.1053/meta.2002.31984
- Yeo SE, Hays NP, Dennis RA, Kortebein PM, Sullivan DH, Evans WJ, Coker RH. Fat distribution and glucose metabolism in older, obese men and women. J Gerontol A Biol Sci Med Sci 2007 Dec;62(12):1393-1401 https://doi.org/10.1093/gerona/62.12.1393
-
Yates AP, Laing I. Age-related increase in haemoglobin A1c and fasting plasma glucose is accompanied by a decrease in
$\beta$ cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnel. Diabet Med 2002;19:254-258 https://doi.org/10.1046/j.1464-5491.2002.00644.x - Kilpatrick ES, Dominiczak MH, Small M. The effects of ageing on glycation and the interpretation of glycaemic control in type 2 diabetes. Q J Med 1996;89:307-312 https://doi.org/10.1093/qjmed/89.4.307
- Brewer N, Wright CS, Travier N, et al. A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care 2008:31:1144-1149 https://doi.org/10.2337/dc07-2374
- Gerstein HC, Swedberg K, Carlsson J, et al. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med 2008;168:1699-1704 https://doi.org/10.1001/archinte.168.15.1699
- Levitan EB, Liu S, Stampfer MJ, et al. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 2008;51:267-275 https://doi.org/10.1007/s00125-007-0882-y
- Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120:720-727 https://doi.org/10.1016/j.amjmed.2007.03.022
- Stout RL, Fulks M, Dolan VF, Magee ME, Suarez L. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants. J Insur Med 2007;39:174-181
- Blake GJ, Pradhan AD, Manson JE, et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 2004;164:757-761 https://doi.org/10.1001/archinte.164.7.757
- Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413-420 https://doi.org/10.7326/0003-4819-141-6-200409210-00006
- Lee YS, Moon SS. The use of HbA1c for diagnosis of type 2 diabetes in Korea. Korean J Med 2011 Mar;80(3):291-297 (Korean)
피인용 문헌
- Correlation between Serum Osteocalcin and Hemoglobin A1c in Gwangju General Hospital Patients vol.50, pp.3, 2018, https://doi.org/10.15324/kjcls.2018.50.3.313